semaglutide and low potassium GLP‑1 medications are becoming more common for diabetes management weight loss, and many patients wonder how they may affect kidney health. Kyle Wood, M.D., MBA, shares insights on current research on Hyperkalemia in Heart Failure with

It would be the first GLP-1based obesity therapy requiring only monthly injections

In February 2025, Hims advertised their semaglutide injections with a Super Bowl commercial

Gastrointestinal adverse effects are among the most commonly reported side effects of GLP-1 therapy, including nausea, vomiting, diarrhoea, and constipation

Once in the central nervous system (CNS), the virus can either reside in a quiescent latent state in this tissue, or eventually actively lead to severe acute necrotizing encephalitis, which is characterized by exacerbated neuroinflammation and prolonged neuroimmune activation producing a life-threatening disease

Dosage and duration should be as advised by the healthcare provider